HIV-Associated Behaviors Among Injecting-Drug Users -- 23 Cities, United States, May 2005-February 2006

Lansky, A.; Drake, A.
April 2009
MMWR: Morbidity & Mortality Weekly Report;4/10/2009, Vol. 58 Issue 13, p329
The article presents the findings of the analysis of data from the National HIV Behavioral Surveillance System (NHBS) collected during May 2005 to February 2006. The analysis was conducted by the U.S. Centers for Disease Control and Prevention (CDC). The analysis has revealed that 31.8% of participating injecting drug users (IDUs) have shared syringes while 62.6% had unprotected vaginal sex. It describes the prevalence of HIV testing among study participants.


Related Articles

  • Developing an HIV Behavioral Surveillance System for Injecting Drug Users: The National HIV Behavioral Surveillance System. Lansky, Amy; Abdul-Quader, Abu S.; Cribbin, Melissa; Hall, Tricia; Finlayson, Teresa J.; Garfein, Richard S.; Lin, Lillian S.; Sullivan, Patrick S. // Public Health Reports;Jan/Feb2007 Supplement, Vol. 122, p48 

    While disease surveillance for HIV/AIDS is now widely conducted in the United States, effective HIV prevention programs rely primarily on changing behavior; therefore, behavioral data are needed to inform these programs. To achieve the goal of reducing HIV infections in the U.S., the Centers for...

  • Acquired Immune Deficiency Syndrome (AIDS).  // World Almanac & Book of Facts;2008, p138 

    An almanac entry for acquired immune deficiency syndrome (AIDS) is presented. The disease is caused by the human immunodeficiency virus (HIV) that kills of disables crucial cells of the immune system, progressively destroying the body's ability to fight disease. The term AIDS applies to the most...

  • The politics of POST-EXPOSURE. Allen, Dan // Advocate;4/12/2005, Issue 936, p40 

    This article discusses the issues pertaining to the post-exposure prophylaxis (PEP) guidelines issued by the U.S. Centers for Disease Control and Prevention in January 2005. In recent years it's become possible for someone exposed to HIV through an incidence of unsafe sex to be given a...

  • Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: A case-case comparison. Bonjour, Maeva A.; Montagne, Morelba; Zambrano, Martha; Molina, Gloria; Lippuner, Catherine; Wadskier, Francis G.; Castrillo, Milvida; Incani, Renzo N.; Tami, Adriana // AIDS Research & Therapy;2008, Vol. 5, Special section p1 

    Background: Although Venezuela has a National Human Immunodeficiency Virus (HIV) Program offering free diagnosis and treatment, 41% of patients present for diagnosis at a later disease-stage, indicating that access to care may still be limited. Our study aimed to identify factors influencing...

  • Availability of Provisional AIDS and HIV/AIDS Data in Table IV and Pediatric HIV Surveillance Data in Table I.  // MMWR: Morbidity & Mortality Weekly Report;4/13/2007, Vol. 56 Issue 14, p343 

    The article reports that the U.S. Centers for Disease Control and Prevention (CDC) is improving the national human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) surveillance data management system. It is said that the CDC will not revise AIDS or HIV/AIDS surveillance data...

  • HIV-2 Infection Surveillance -- United States, 1987--2009. Torian, Lucia V.; Selik, Richard M.; Branson, Bernard; Owen, S. Michele; Granade, Timothy; Shouse, R. Luke; Joyce, M. Patricia; Pieniazek, Danuta; Kline, Richard // MMWR: Morbidity & Mortality Weekly Report;7/29/2011, Vol. 60 Issue 29, p985 

    The article focuses on the U.S. Center for Disease Control and Prevention (CDC) surveillance for the human immunodeficiency virus (HIV) from 1987 to 2009. Causing the acquired immunodeficiency syndrome (AIDS), HIV-1 and HIV-2 types have the same transmission routes but HIV-2 is confined to...

  • Counseling, Testing, and Referral for HIV. Gangel, Elaine Kierl; Preboth, Monica // American Family Physician;4/1/2002, Vol. 65 Issue 7, p1470 

    Reports on updated guidelines issued by the United States Centers for Disease Control and Prevention for use in developing services and policies for human immunodeficiency virus (HIV) counseling, testing and referral. Description of the guidelines; Intent of the guidelines to be used in...

  • HIV Prevalence Rates among Injection Drug Users in 96 Large US Metropolitan Areas, 1992–2002. Tempalski, Barbara; Lieb, Spencer; Cleland, Charles M.; Cooper, Hannah; Brady, Joanne E.; Friedman, Samuel R. // Journal of Urban Health;Jan2009, Vol. 86 Issue 1, p132 

    This research presents estimates of HIV prevalence rates among injection drug users (IDUs) in large US metropolitan statistical areas (MSAs) during 1992–2002. Trend data on HIV prevalence rates in geographic areas over time are important for research on determinants of changes in HIV...

  • Rapid Increase in HIV Rates—Orel Oblast, Russian Federation, 1999-2001.  // JAMA: Journal of the American Medical Association;8/13/2003, Vol. 290 Issue 6, p747 

    Reports on the rapid increases in the estimated number of cases of human immunodeficiency virus (HIV) reported officially in the Russian Federation. Collaboration between the U.S. Centers for Disease Control and Prevention and the Orel Oblast AIDS and Infectious Diseases Prevention Center to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics